Accreditation

  • Accreditation Council for Continuing Medical Education (ACCME)

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).

    CME/CE Credit Offered:
    • AMA PRA Category 1 CreditTM
    • American Nurses Credentialing Center
    • American Board of Cardiovascular Perfusion
    • American Association for Respiratory Care

    Physicians should only claim credit commensurate with the extent of their participation in the activity.

Our Purpose

ECMO use is rapidly expanding. A gap exists between centers that are developing ECMO programs, and centers that have experienced the benefits of having well-developed ECMO programs in place. Our purpose is to provide healthcare professionals with a systematic approach to caring for critically ill patients that will ultimately improve the care of their patients.
LEARN MORE ABOUT PROGRAM

Course Details

  • General Information

    Up to 10.0 AMA PRA Category 1 Credits ™

    Release Date: 10/2/2020
    Review Date: 5/8/2023
    Expiration Date: 5/8/2024
    Format: Internet-based Video

  • Registration Fees

    Single User: $999

  • Statement of Purpose

    ECMO use is rapidly expanding. A gap exists between centers that are developing ECMO programs, and centers that have experienced the benefits of having well-developed ECMO programs in place.

    This course will allow for the development of core concepts which will then be developed, expanded, and incorporated into a systematic approach to patients on ECMO. Ultimately, this will improve understanding and allow for better patient care.

  • Learning Objectives

    Upon completion of this course, participants should be able to:

    Physiology

    1. Describe the parameters for oxygen delivery.

    2. Compare the effect of manipulation of various components of oxygen delivery.

    3. Recognize shock and describe the limitations of clinical and laboratory findings.

    4. Understand the limits of critical care interventions to optimize oxygen delivery and recognize the toxicity of these interventions.

    ECMO Fundamentals

    5. Name the specific components and their function.

    6. Identify ways to monitor the ECMO circuit: pressures, alarms, sensors.

    7. Apply a systematic approach to selecting patients for ECMO.

    8. Compare the various configurations used for ECMO cannulation, and identify the reasons for different strategies.

    ECMO Physiology

    9. Describe characteristics which limit blood flow to the ECMO circuit.

    10. Appraise the limits of the ECMO membrane.

    11. Assess the reasons for hypoxia on VV ECMO and apply a method for diagnosing and treating.

    12. Identify patient characteristics that are ideal for VA ECMO.

    13. Understand the physiology of retrograde flow and its consequences related to VA ECMO.

    ECMO Management

    14. Apply physiological concepts to develop an approach toward titration of flow.

    15. Develop a method for managing the ventilator for patients on ECMO that spares the toxicity of conventional therapy.

    16. Describe pharmacokinetic principles common to patients on ECMO and apply to how drugs are administered.

    17. Understand the principles related to coagulation and apply these to how anticoagulation is employed in a patient on ECMO.

  • Target Audience

    This activity is designed for physicians, advanced practice providers, nurses, respiratory therapists, perfusionists.

  • Accreditation

    Physicians
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company and the Institute for Extracorporeal Life Support. Antidote is accredited by the ACCME to provide continuing medical education for physicians.

    Antidote designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Respiratory Therapists
    This program has been approved for a maximum of 10.00 contact hour(s) Continuing Respiratory Care Education. (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063
    Course # 190070000

    Perfusionists
    The American Board of Cardiovascular Perfusion (ABCP) has approved The ECMO Course for a total of 12.0 Category I CEUs.

  • Agenda

    Physiology (5 sessions)
    ECMO Fundamentals (4 sessions)
    ECMO Physiology (6 sessions)
    ECMO Management (5 sessions)

  • Presenting Faculty

    Jeffrey DellaVolpe, MD - Director, Methodist ECMO Program; Medical Director, Cardiovascular ICU, Methodist Hospital; Director, ICU Service Line, Texas IPS, San Antonio, TX.

    Board Certifications
    American Board of Internal Medicine, Internal Medicine
    American Board of Internal Medicine, Critical Care Medicine

    Fellowship
    Critical Care Medicine- University Pittsburgh, PA, 2015

    Residency
    Tulane Internal Medicine, New Orleans, LA

    Education
    Undergraduate – Dartmouth College, Hanover, NH
    Medical School – Tulane University School of Medicine, New Orleans, LA

    Areas of Expertise
    Critical Care
    ECMO

  • Method of Participation

    Read the learning objectives and faculty disclosures.

    View the videos in their entirety.

    Complete the post lesson quiz. A score of 100% is needed to proceed to the next lesson.

  • Disclosure

    In accordance with The Standards for Integrity and Independence in Accredited Continuing Education promulgated by the Accreditation Council for Continuing Medical Education (“ACCME”), it is the policy of Antidote Education Company that all individuals in a position to control the content of an activity disclose all financial relationships with any ineligible company to Antidote prior to the activity. A relevant financial relationship is defined as any financial relationship in any amount occurring within the past 24 months with an ineligible company. A relevant financial relationship exists when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he or she has a financial relationship. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    Antidote has established mechanisms to mitigate any relevant financial relationships disclosed or otherwise identified to ensure independence in all of its educational activities. If, through the application of these mechanisms, an individual’s relevant financial relationships cannot be resolved, that individual is prohibited from participating in the activity in question in any manner. The relevant financial relationships, if any, of the individuals in a position to control the content of this educational activity have been mitigated through Antidote’s conflict resolution mechanism. Nonetheless, the relevant financial relationships, if any, of each individual in a position to control the content of this educational activity have been disclosed to you below. If an individual has no relevant financial relationships, that fact is also provided to you.

    The following presenters, planners and reviewers have no relevant financial relationships with an ineligible company:
    Jeffrey DellaVolpe, MD; Craig Ainsworth, MD; Matthew Fleming (Antidote Education Company)

  • Disclaimer

    The material presented in this course is being made available by Antidote Education Company the Institute for Extracorporeal Life Support for educational purposes only. This material is not intended to represent the best or only methods or procedures appropriate for the medical situations discussed, but rather is intended to present an approach, view, statement or opinion of the faculty which may be helpful to others who face similar situations. Opinions expressed in this activity are those of the faculty and not of Antidote.

    Every effort has been made to assure the accuracy of the data presented at this course. Physicians may care to check specific details such as drug doses and contraindications in standard sources prior to clinical application.

  • Off-label or Investigational Use

    Use of extracorporeal life support for greater than 6 hours is considered off label.

  • Privacy Policy

    View our Privacy Policy here.